These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4084656)

  • 1. Minor graft-versus-host reaction: very early effects on hepatic and exocrine pancreatic functions in mice.
    Khairallah M; Spach C
    Biomed Pharmacother; 1985; 39(5):226-32. PubMed ID: 4084656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
    Halle-Pannenko O; Pritchard LL; Rappaport H
    Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune reactions against pancreatic islets as a consequence of graft versus host disease.
    Kolb H; Freytag G; Kiesel U; Kolb-Bachofen V
    Clin Exp Immunol; 1981 Jan; 43(1):121-7. PubMed ID: 7018756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LF 08-0299 protects murine recipients of minor antigen disparate donor bone marrow from lethal graft-versus-host disease.
    Bruley-Rosset M; Churaqui E; Annat J; Dutartre P
    Transplant Proc; 1996 Dec; 28(6):3114-6. PubMed ID: 8962208
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
    Nagler A; Pines M; Abadi U; Pappo O; Zeira M; Rabbani E; Engelhardt D; Ohana M; Chowdhury NR; Chowdhury JR; Ilan Y
    Hepatology; 2000 Mar; 31(3):641-8. PubMed ID: 10706554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.
    Schirrmacher V; Müerköster S; Umansky V
    Clin Cancer Res; 1998 Nov; 4(11):2635-45. PubMed ID: 9829726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.
    Perreault C; Jutras J; Roy DC; Filep JG; Brochu S
    J Clin Invest; 1996 Aug; 98(3):622-8. PubMed ID: 8698852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytokine production associated with distinct phases of murine graft-versus-host reaction.
    Garside P; Reid S; Steel M; Mowat AM
    Immunology; 1994 Jun; 82(2):211-4. PubMed ID: 7927491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoid cell proliferation in non-lymphoid organs during graft-versus-host reactions (GVHR): I. Lack of correlation between mortality and grafted cell proliferation.
    Spach C; Motta R
    Exp Hematol; 1981 May; 9(5):531-9. PubMed ID: 7238660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the repertoire of T-cell lines and clones specific for minor histocompatibility antigens derived from immunized mice and from mice developing a graft-versus-host reaction.
    Bruley-Rosset M; Miconnet I; Roger T; Seman M; Halle-Pannenko O
    Transplant Proc; 1993 Feb; 25(1 Pt 1):94-5. PubMed ID: 8438503
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens.
    Krenger W; Snyder K; Smith S; Ferrara JL
    Transplantation; 1994 Dec; 58(11):1251-7. PubMed ID: 7992370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction.
    Murai M; Yoneyama H; Ezaki T; Suematsu M; Terashima Y; Harada A; Hamada H; Asakura H; Ishikawa H; Matsushima K
    Nat Immunol; 2003 Feb; 4(2):154-60. PubMed ID: 12524535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    Ellison CA; Fischer JM; HayGlass KT; Gartner JG
    J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
    Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
    Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.